AL, USA); 1,2-dioleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (DOPG; Avanti Polar Lipids); n-decane (Wako Pure Chemical Industries, Ltd., Osaka, Japan); 3-morpholinopropane-1-sulfonic
acid (MOPS, Nacalai Tesque, Kyoto, Japan); potassium chloride (KCl;
Nacalai Tesque); clavanin A (GenScript); cecropin A (BACHEM); pardaxin
(abcam); magainin 1 (AnaSpec Inc); SL-37 (Cosmo Bio Co., Ltd.); and
LL-37 (AnaSpec Inc.). DOPE and DOPG were melted in n-decane at a concentration of 10 mg/mL, and we obtained a lipid mixture
of DOPE/DOPG (3:1 mol/mol). The composition of the measurement buffer
was regulated so that it became 200 mM KCl, 10 mM MOPS, and pH 7.0
in the Milli-Q system (Millipore, Billerica, MA, USA). The clavanin
A, cecropin A, pardaxin, magainin 1, SL-37, and LL-37 powders were
dissolved in the measurement buffer and preserved at 4 °C.